Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,804,973
-
Share change
-
-58,782
-
Total reported value
-
$19,401,935
-
Price per share
-
$10.75
-
Number of holders
-
32
-
Value change
-
-$644,609
-
Number of buys
-
13
-
Number of sells
-
11
Institutional Holders of OPIANT PHARMACEUTICALS INC - COM (OPNT) as of Q3 2022
As of 30 Sep 2022,
OPIANT PHARMACEUTICALS INC - COM (OPNT) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,804,973 shares.
The largest 10 holders included
HealthInvest Partners AB, WELLS FARGO & COMPANY/MN, Apis Capital Advisors, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Stonepine Capital Management, LLC, ACADIAN ASSET MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, Parkman Healthcare Partners LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.